About Metafora Biosystems
Metafora Biosystems is a Healthcare company based in Paris (France) founded in 2011 by Luc Dauriol, Vincent Petit, and Marc Sitbon. Diagnostic tests and research reagents are provided for biomedical analysis. Its chief executive, as recorded, is Vincent Petit. Metafora Biosystems offers products and services including METAflow and METAglut1™. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Diversified and Rare Diseases.
Company details
Metafora biosystems offers diagnostic tests and research reagents (IVD platform for drug discovery, development). They have developed few probes called RBDs which attaches to the transporters to analyze their quantity. Using the technology they have developed METAglut1 blood test to diagnose the GLUT1 deficiency syndrome (GLUT1 DS) which happens because of impairment of the major glucose transporter 1. It has an ability to target nutrient transporters at the cell surface.
- Headquarters Paris, France
- Founders Luc Dauriol, Vincent Petit, Marc Sitbon
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website metafora-biosystems.com/wp-signup.php
- Social LinkedIn Facebook
- Latest Funding Round$2.68M (USD), Grant
Jan 2023
- InvestorsEuropean Union
& 1 more
Products & Services of Metafora Biosystems
Metafora Biosystems offers a comprehensive portfolio of products and services, including METAflow and METAglut1™.
AI software for analyzing flow and mass cytometry data in research
Blood test for diagnosing Glut1 Deficiency Syndrome accurately
Funding Insights of Metafora Biosystems
- Total Rounds 8
- Last Round Grant — $2.68M
- First Round $52,286
(Jan 2017)
- Investors Count 2
All 8 funding rounds of Metafora Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $2.68M | Grant | – | – | |
| Oct 2022 | $8.51M | Grant | – | – | |
| Jun 2020 | $3.6M | Grant | – | – | |
| Jun 2018 | $3.77M | Grant | – | – | |
| Feb 2018 | $3.97M | Grant | – | – | |
| May 2017 | $55,770 | Grant | – | – | |
| Feb 2017 | $53,830 | Grant | – | – | |
| Jan 2017 | $52,286 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Metafora Biosystems
Metafora Biosystems has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Metafora Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Metafora Biosystems
3 people are tracked at Metafora Biosystems (3 in leadership).
| Name | Role | Group |
|---|---|---|
Luc Dauriol | Co-Founder & Chairman | Leadership |
Vincent Petit | Co-Founder & CEO | Leadership |
Marc Sitbon | Co-Founder & President | Leadership |
Complete people profiles for Metafora Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Metafora Biosystems
3 dated milestones of Metafora Biosystems across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Metafora Biosystems is founded.
- Funding First funding round of $52K.
- Funding Latest funding round, Grant, of $2.7M.
Web traffic of Metafora Biosystems
The website of Metafora Biosystems (metafora-biosystems.com) receives about 2K visits a month.
- Monthly visits2K
▲ 291.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Metafora Biosystems
Complete news archive for Metafora Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metafora Biosystems
Metafora Biosystems was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Metafora Biosystems is headquartered in Paris, France.
Vincent Petit is the CEO of Metafora Biosystems, as recorded in our data. They have also founded this company.
Metafora biosystems offers diagnostic tests and research reagents (IVD platform for drug discovery, development). They have developed few probes called RBDs which attaches to the transporters to analyze their quantity. Using the technology they have developed METAglut1 blood test to diagnose the GLUT1 deficiency syndrome (GLUT1 DS) which happens because of impairment of the major glucose transporter 1. It has an ability to target nutrient transporters at the cell surface.
Metafora Biosystems offers METAflow and METAglut1™.
Metafora Biosystems has 2 investors. Key investors include European Union, and EIC Fund.